Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
108
NCT00658437
CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2008
Completion: May 31, 2010
NCT00932724
CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
Start: Jul 31, 2009
Completion: Aug 31, 2012